Compare FLUX & BNGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FLUX | BNGO |
|---|---|---|
| Founded | N/A | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Laboratory Analytical Instruments |
| Sector | Miscellaneous | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.1M | 24.3M |
| IPO Year | N/A | 2018 |
| Metric | FLUX | BNGO |
|---|---|---|
| Price | $1.31 | $1.12 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | ★ $8.00 | $6.33 |
| AVG Volume (30 Days) | 139.0K | ★ 315.2K |
| Earning Date | 02-12-2026 | 03-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $63,484,000.00 | $28,720,000.00 |
| Revenue This Year | $0.18 | N/A |
| Revenue Next Year | $29.72 | $24.27 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 2.13 | N/A |
| 52 Week Low | $1.06 | $1.06 |
| 52 Week High | $7.55 | $6.32 |
| Indicator | FLUX | BNGO |
|---|---|---|
| Relative Strength Index (RSI) | 47.22 | 27.66 |
| Support Level | $1.06 | $1.06 |
| Resistance Level | $1.47 | $1.23 |
| Average True Range (ATR) | 0.12 | 0.11 |
| MACD | 0.00 | -0.03 |
| Stochastic Oscillator | 59.16 | 10.94 |
Flux Power Holdings Inc design, develop, manufacture, and sell a portfolio of lithium-ion energy storage solutions for electrification of a range of industrial commercial sectors which include material handling, airport ground support equipment (GSE), and other commercial and industrial applications. It offers a high-power battery cell management system(BMS). The company's BMS provides three functions to its battery systems which include Cell Balancing, Monitoring, and Error Reporting.
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in Americas, EMEA and Asia Pacific; majority revenue being generated from Americas. They generate product revenue from sales of its OGM and Ionic Purification systems and consumables, which includes its instruments, and their VIA software.